Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Cullinan Therapeutics Inc have a median target of 30.00, with a high estimate of 40.00 and a low estimate of 28.00. The median estimate represents a 87.27% increase from the last price of 16.02.
High | 149.7% | 40.00 |
Med | 87.3% | 30.00 |
Low | 74.8% | 28.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 12, 2025.
Average growth rate | +0.55% |
Average growth rate | +72.26% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -50.00% |
More ▼